Comments
Loading...

BioNTech Analyst Ratings

BNTXNASDAQ
Logo brought to you by Benzinga Data
$97.80
5.035.42%
At close: -
$97.80
0.000.00%
After Hours: 4:00 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$216.00
Lowest Price Target1
$111.00
Consensus Price Target1
$146.57

BioNTech Analyst Ratings and Price Targets | NASDAQ:BNTX | Benzinga

BioNTech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for BioNTech Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Jan
4
Mar
1
Apr
3
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Citigroup
Morgan Stanley
Canaccord Genuity
BMO Capital

1calculated from analyst ratings

Analyst Ratings for BioNTech

Buy NowGet Alert
05/14/2025Buy NowHC Wainwright & Co.
Robert Burns42%
$145 → $134MaintainsBuyGet Alert
05/06/2025Buy NowCitigroup
Geoff Meacham60%
$145 → $140MaintainsBuyGet Alert
05/06/2025Buy NowMorgan Stanley
Terence Flynn63%
$140 → $132MaintainsOverweightGet Alert
04/01/2025Buy NowHC Wainwright & Co.
Robert Burns42%
$150 → $145MaintainsBuyGet Alert
03/13/2025Buy NowCitigroup
Geoff Meacham60%
→ $145Initiates → BuyGet Alert
03/11/2025Buy NowMorgan Stanley
Terence Flynn63%
$145 → $139MaintainsOverweightGet Alert
03/11/2025Buy NowCanaccord Genuity
John Newman43%
$171.44 → $171.44MaintainsBuyGet Alert
03/11/2025Buy NowBMO Capital
Etzer Darout44%
$130 → $143MaintainsOutperformGet Alert
01/10/2025Buy NowTruist Securities
Asthika Goonewardene41%
→ $172Initiates → BuyGet Alert
12/11/2024Buy NowWells Fargo
Mohit Bansal66%
→ $170Initiates → OverweightGet Alert
11/27/2024Buy NowCanaccord Genuity
William Maughan71%
$171 → $171.44MaintainsBuyGet Alert
11/26/2024Buy NowJP Morgan
Jessica Fye63%
$124 → $122MaintainsNeutralGet Alert
11/19/2024Buy NowEvercore ISI Group
Cory Kasimov67%
$110 → $125UpgradeIn-Line → OutperformGet Alert
11/18/2024Buy NowCanaccord Genuity
John Newman43%
$171 → $171MaintainsBuyGet Alert
11/18/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$150 → $150ReiteratesBuy → BuyGet Alert
11/14/2024Buy NowCanaccord Genuity
John Newman43%
$171 → $171MaintainsBuyGet Alert
11/08/2024Buy NowGoldman Sachs
Chris Shibutani54%
$90 → $137UpgradeNeutral → BuyGet Alert
11/06/2024Buy NowTD Cowen
Yaron Werber35%
$132 → $122MaintainsHoldGet Alert
11/05/2024Buy NowTD Cowen
Yaron Werber35%
$132 → $122MaintainsHoldGet Alert
11/04/2024Buy NowJP Morgan
Jessica Fye63%
$125 → $124MaintainsNeutralGet Alert
10/07/2024Buy NowHSBC
Yifeng Liu31%
$97 → $136MaintainsBuyGet Alert
10/07/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $150MaintainsBuyGet Alert
09/24/2024Buy NowMorgan Stanley
Terence Flynn63%
$93 → $145UpgradeEqual-Weight → OverweightGet Alert
09/19/2024Buy NowDeutsche Bank
Emmanuel Papadakis47%
$95 → $150MaintainsBuyGet Alert
09/18/2024Buy NowUBS
Eliana Merle41%
$97 → $131MaintainsNeutralGet Alert
09/17/2024Buy NowJefferies
Akash Tewari41%
$96 → $150UpgradeHold → BuyGet Alert
09/16/2024Buy NowJP Morgan
Jessica Fye63%
$91 → $125UpgradeUnderweight → NeutralGet Alert
09/16/2024Buy NowB of A Securities
Tazeen Ahmad54%
$125 → $150MaintainsBuyGet Alert
09/16/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
09/13/2024Buy NowJefferies
Akash Tewari41%
$90 → $96MaintainsHoldGet Alert
08/27/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
08/19/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
08/15/2024Buy NowJP Morgan
Jessica Fye63%
$94 → $91MaintainsUnderweightGet Alert
08/07/2024Buy NowDeutsche Bank
Emmanuel Papadakis47%
$95 → $95UpgradeHold → BuyGet Alert
08/06/2024Buy NowTD Cowen
Yaron Werber35%
$98 → $85MaintainsHoldGet Alert
08/01/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
06/26/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
06/12/2024Buy NowJP Morgan
Jessica Fye63%
$90 → $94MaintainsUnderweightGet Alert
06/10/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
06/04/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
06/03/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
05/30/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
05/28/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
05/24/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$113 → $113ReiteratesBuy → BuyGet Alert
05/14/2024Buy NowEvercore ISI Group
Cory Kasimov67%
→ $100Initiates → In-LineGet Alert
05/08/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$107 → $113MaintainsBuyGet Alert
05/07/2024Buy NowTD Cowen
Yaron Werber35%
$95 → $98MaintainsHoldGet Alert
05/07/2024Buy NowBMO Capital
Etzer Darout44%
$123 → $122MaintainsOutperformGet Alert
04/17/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$107 → $107ReiteratesBuy → BuyGet Alert
03/27/2024Buy NowUBS
Eliana Merle41%
$110 → $101MaintainsNeutralGet Alert
03/22/2024Buy NowJP Morgan
Jessica Fye63%
$99 → $90MaintainsUnderweightGet Alert
03/21/2024Buy NowCanaccord Genuity
John Newman43%
$171 → $171ReiteratesBuy → BuyGet Alert
03/21/2024Buy NowBMO Capital
Etzer Darout44%
$127 → $123MaintainsOutperformGet Alert
02/28/2024Buy NowGoldman Sachs
Chris Shibutani54%
$113 → $100MaintainsNeutralGet Alert
02/23/2024Buy NowCanaccord Genuity
John Newman43%
$171 → $171ReiteratesBuy → BuyGet Alert
02/23/2024Buy NowBMO Capital
Etzer Darout44%
→ $127Initiates → OutperformGet Alert
02/21/2024Buy NowCanaccord Genuity
John Newman43%
$171 → $171ReiteratesBuy → BuyGet Alert
02/20/2024Buy NowCanaccord Genuity
John Newman43%
$168 → $171MaintainsBuyGet Alert
01/23/2024Buy NowHC Wainwright & Co.
Robert Burns42%
$133 → $107MaintainsBuyGet Alert
12/01/2023Buy NowJP Morgan
Jessica Fye63%
$106 → $99DowngradeNeutral → UnderweightGet Alert
11/27/2023Buy NowHC Wainwright & Co.
Robert Burns42%
→ $133ReiteratesBuy → BuyGet Alert
11/14/2023Buy NowHC Wainwright & Co.
Robert Burns42%
$180 → $133MaintainsBuyGet Alert
11/08/2023Buy NowMorgan Stanley
Matthew Korn45%
$110 → $111MaintainsEqual-WeightGet Alert
10/17/2023Buy NowMorgan Stanley
Matthew Korn45%
$116 → $110MaintainsEqual-WeightGet Alert
10/16/2023Buy NowHSBC
Yifeng Liu31%
$124 → $111DowngradeBuy → HoldGet Alert
08/28/2023Buy NowHC Wainwright & Co.
Robert Burns42%
→ $180ReiteratesBuy → BuyGet Alert
08/10/2023Buy NowHC Wainwright & Co.
Robert Burns42%
$181 → $180MaintainsBuyGet Alert
08/08/2023Buy NowMorgan Stanley
Matthew Korn45%
$119 → $116MaintainsEqual-WeightGet Alert
08/01/2023Buy NowMorgan Stanley
Matthew Korn45%
$119 → $119ReiteratesEqual-Weight → Equal-WeightGet Alert
07/31/2023Buy NowMorgan Stanley
Matthew Korn45%
$119 → $119ReiteratesEqual-Weight → Equal-WeightGet Alert
07/24/2023Buy NowMorgan Stanley
Matthew Korn45%
$119 → $119ReiteratesEqual-Weight → Equal-WeightGet Alert
07/17/2023Buy NowMorgan Stanley
Matthew Korn45%
$119 → $119ReiteratesEqual-Weight → Equal-WeightGet Alert
07/14/2023Buy NowHSBC
Rajesh Kumar61%
→ $124Initiates → BuyGet Alert
07/11/2023Buy NowMorgan Stanley
Matthew Korn45%
$124 → $119MaintainsEqual-WeightGet Alert
06/26/2023Buy NowMorgan Stanley
Matthew Korn45%
$124 → $124ReiteratesEqual-Weight → Equal-WeightGet Alert
06/20/2023Buy NowMorgan Stanley
Matthew Korn45%
→ $124ReiteratesEqual-Weight → Equal-WeightGet Alert
06/16/2023Buy NowCanaccord Genuity
John Newman43%
$203 → $203ReiteratesBuy → BuyGet Alert
06/12/2023Buy NowMorgan Stanley
Matthew Korn45%
→ $124Reiterates → Equal-WeightGet Alert
06/09/2023Buy NowHC Wainwright & Co.
Robert Burns42%
→ $181Reiterates → BuyGet Alert
06/01/2023Buy NowHC Wainwright & Co.
Robert Burns42%
$198 → $181MaintainsBuyGet Alert
05/23/2023Buy NowHC Wainwright & Co.
Robert Burns42%
$210 → $198MaintainsBuyGet Alert
05/18/2023Buy NowDeutsche Bank
Emmanuel Papadakis47%
$135 → $120MaintainsHoldGet Alert
05/17/2023Buy NowRedburn Partners
Simon Baker24%
$165 → $170UpgradeNeutral → BuyGet Alert
05/09/2023Buy NowMorgan Stanley
Matthew Korn45%
$150 → $124MaintainsEqual-WeightGet Alert
04/24/2023Buy NowDeutsche Bank
Emmanuel Papadakis47%
$160 → $135MaintainsHoldGet Alert
04/10/2023Buy NowJP Morgan
Jessica Fye63%
$142 → $128MaintainsNeutralGet Alert
03/31/2023Buy NowUBS
Eliana Merle41%
$168 → $153MaintainsNeutralGet Alert
03/30/2023Buy NowHC Wainwright & Co.
Robert Burns42%
→ $210Reiterates → BuyGet Alert
03/28/2023Buy NowCanaccord Genuity
William Maughan71%
$191 → $203MaintainsBuyGet Alert
03/28/2023Buy NowTD Cowen
Yaron Werber35%
$145 → $130MaintainsMarket PerformGet Alert
03/28/2023Buy NowB of A Securities
Tazeen Ahmad54%
$239 → $194MaintainsBuyGet Alert
03/28/2023Buy NowMorgan Stanley
Matthew Korn45%
$216 → $150MaintainsEqual-WeightGet Alert
03/28/2023Buy NowGoldman Sachs
Chris Shibutani54%
$156 → $140MaintainsNeutralGet Alert
03/23/2023Buy NowHC Wainwright & Co.
Robert Burns42%
$272 → $210MaintainsBuyGet Alert
02/08/2023Buy NowJP Morgan
Jessica Fye63%
$148 → $142MaintainsNeutralGet Alert
01/31/2023Buy NowGoldman Sachs
Chris Shibutani54%
$177 → $156MaintainsNeutralGet Alert
01/24/2023Buy NowMorgan Stanley
Matthew Harrison60%
$203 → $216MaintainsEqual-WeightGet Alert
12/15/2022Buy NowB of A Securities
Tazeen Ahmad54%
→ $239UpgradeNeutral → BuyGet Alert
11/11/2022Buy NowDeutsche Bank
Emmanuel Papadakis47%
$180 → $160MaintainsHoldGet Alert
11/08/2022Buy NowMorgan Stanley
Matthew Harrison60%
$194 → $203MaintainsEqual-WeightGet Alert

FAQ

Q

What is the target price for BioNTech (BNTX) stock?

A

The latest price target for BioNTech (NASDAQ:BNTX) was reported by HC Wainwright & Co. on May 14, 2025. The analyst firm set a price target for $134.00 expecting BNTX to rise to within 12 months (a possible 37.01% upside). 44 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for BioNTech (BNTX)?

A

The latest analyst rating for BioNTech (NASDAQ:BNTX) was provided by HC Wainwright & Co., and BioNTech maintained their buy rating.

Q

When was the last upgrade for BioNTech (BNTX)?

A

The last upgrade for BioNTech SE happened on November 19, 2024 when Evercore ISI Group raised their price target to $125. Evercore ISI Group previously had an in-line for BioNTech SE.

Q

When was the last downgrade for BioNTech (BNTX)?

A

The last downgrade for BioNTech SE happened on December 1, 2023 when JP Morgan changed their price target from $106 to $99 for BioNTech SE.

Q

When is the next analyst rating going to be posted or updated for BioNTech (BNTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioNTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioNTech was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.

Q

Is the Analyst Rating BioNTech (BNTX) correct?

A

While ratings are subjective and will change, the latest BioNTech (BNTX) rating was a maintained with a price target of $145.00 to $134.00. The current price BioNTech (BNTX) is trading at is $97.80, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch